Full text is available at the source.
Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate–activated protein kinase in human HepG2 cells and obese mice
Purple sweet potato compounds reduce liver fat by activating energy control in human liver cells and obese mice
AI simplified
Abstract
Anthocyanin fraction (200 mg/kg per day) reduced weight gain and hepatic triglyceride accumulation in high-fat diet-fed mice over 4 weeks.
- The anthocyanin fraction from purple sweet potato is associated with reduced hepatic lipid accumulation.
- Increased phosphorylation of AMPK and acetyl-coenzyme A carboxylase was observed in the liver and HepG2 hepatocytes after treatment with anthocyanin fraction.
- The treatment led to down-regulation of sterol regulatory element-binding protein 1 and its target genes, including acetyl-coenzyme A carboxylase and fatty acid synthase.
- The specific AMPK inhibitor compound C reduced the effects of the anthocyanin fraction on lipid metabolism-related proteins in HepG2 hepatocytes.
- These findings suggest that anthocyanin fraction may influence hepatic lipid metabolism through AMPK signaling pathways.
AI simplified